| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/31/2008 | US20080026057 Process for the Preparation of a Solid, Orally Administrable Pharmaceutical Composition |
| 01/31/2008 | US20080026050 Solid dose formulations of a thrombin receptor antagonist |
| 01/31/2008 | US20080026049 Liposomal compositions for parenteral delivery of agents |
| 01/31/2008 | US20080025978 High affinity ligand for p75 neurotrophin receptor |
| 01/31/2008 | US20080025970 Treatment of atherosclerosis |
| 01/31/2008 | US20080025956 Blood vessel formation from endothelial colony forming cells |
| 01/31/2008 | US20080025955 Method Of Producing Vascular Endothelial Cells From Primate Embryonic Stem Cells |
| 01/31/2008 | US20080025954 Use of Gingival Fibroblasts for Vascular Cell Therapy |
| 01/31/2008 | US20080025919 Benzoylguanidine salt and hydrates thereof |
| 01/31/2008 | DE102006034256A1 Verbesserung der Bioverfügbarkeit von Wirkstoffen mit Amidinfunktion in Arzneimitteln Improve the bioavailability of drugs with amidine in drugs |
| 01/31/2008 | CA2657202A1 Extended release pharmaceutical formulation of metoprolol and process for its preparation |
| 01/30/2008 | EP1882695A2 Pharmaceutically active compounds and methods of use thereof |
| 01/30/2008 | EP1882690A2 A process for the preparation of epothilone analogs and intermediates |
| 01/30/2008 | EP1882686A2 Pyrrolidine and piperidine derivates as nk1 antagonists |
| 01/30/2008 | EP1881991A1 A1 adenosine receptor agonists |
| 01/30/2008 | EP1881985A2 Anhydrous crystalline forms of n-ý1-(2-ethoxyethyl)-5-(n-ethyl-n-methylamino)-7-(4-methylpyridin-2-yl-amino)-1h-pyrazolo[4,3-d]pyrimidine-3-carbonyl¨methanesulfonamide |
| 01/30/2008 | EP1881962A2 Thiosuccinic acid derivatives and the use thereof |
| 01/30/2008 | EP1881841A1 Compositions comprising tripeptides inhibiting ace |
| 01/30/2008 | EP1881826A1 Use of a benzoyl derivative of 3-aminocarbazole for the treatment of a disorder associated with the production of prostaglandin e2 (pge2) |
| 01/30/2008 | EP0941125B1 Methods for regulating angiogenesis |
| 01/30/2008 | CN101115497A Food for preventing life style-related diseases |
| 01/30/2008 | CN101115491A Therapeutic agent |
| 01/30/2008 | CN101115480A Therapeutic combinations of manidi pine and a statin |
| 01/30/2008 | CN101113162A Method for extracting centipede acidic protein and application of centipede acidic protein extracted by the method in preparation of medicine for treating heart disease |
| 01/30/2008 | CN101113157A Isoamylene radical chromocor derivative, preparation method and uses thereof |
| 01/30/2008 | CN101113149A Aliphatic organic acid salt of berberine type alkaloid and preparation method and usage thereof |
| 01/30/2008 | CN101112603A Cardiac and cerebral vascular disease treating medicine and method for preparing the same |
| 01/30/2008 | CN101112595A Chinese patent medicine for treating diabetic cardiac disease |
| 01/30/2008 | CN101112593A Chinese traditional medicine composition for treating diabetic cardiac disease |
| 01/30/2008 | CN101112551A Composition comprising bamboo extract and the compounds isolated therefrom showing treating and preventing activity for inflammatory and blood circulation disease |
| 01/30/2008 | CN101112549A Chinese patent drug for treating diabetic hypertension |
| 01/30/2008 | CN101112544A Bag tea, oral liquid or pills for treating hypertension |
| 01/30/2008 | CN101112539A Chinese patent medicine for treating diabetic cerebral apoplexy |
| 01/30/2008 | CN101112538A Chinese traditional medicine preparations for treating diabetic hypertension |
| 01/30/2008 | CN101112525A Health products having functions of invigorating qi and blood and restoring consciousness and refreshing oneself |
| 01/30/2008 | CN101112517A Chinese traditional medicine compounding for treating diabetic cardiac disease |
| 01/30/2008 | CN101112516A Chinese patent medicine for treating diabetic cardiac disease |
| 01/30/2008 | CN101112515A Chinese traditional medicine compounding for treating diabetic cardiac disease |
| 01/30/2008 | CN101112514A Chinese medicine preparation for treating diabetic cardiac disease |
| 01/30/2008 | CN101112502A Chinese traditional medicine composition for treating diabetic cerebral apoplexy |
| 01/30/2008 | CN101112501A Chinese traditional medicine composition for treating diabetic hypertension |
| 01/30/2008 | CN101112494A Medicine for treating coronary disease and method for preparing the same |
| 01/30/2008 | CN101112492A Chinese traditional medicine preparations for treating diabetic hypertension |
| 01/30/2008 | CN101112463A Composition of the compatibility of blueberry fruit and vine seed with svitamin C and vitamin E |
| 01/30/2008 | CN101112459A Smelly phoenix tree extract, method for preparing the same and use thereof |
| 01/30/2008 | CN101112433A Chinese traditional medicine compounding for treating diabetic cerebral apoplexy |
| 01/30/2008 | CN101112408A Sustained-release ji chrysanthemum tablet and method for preparing the same |
| 01/30/2008 | CN101112405A Drug for curing coronary disease and method for preparing the same |
| 01/30/2008 | CN101112394A Bdella micro-powder preparations for treating cardio-cerebralvascular disease |
| 01/30/2008 | CN101112376A Toothpaste for nursing cardiac and cerebral blood vessel |
| 01/30/2008 | CN101112364A Hepadestal preparations and method for preparing the same |
| 01/30/2008 | CN100364978C Composition, process of making, and medical use of substituted 4-phenyltetrahydroisoquinolines |
| 01/30/2008 | CN100364971C Pyrrolidine-2-ones as factor Xa inhibitors |
| 01/30/2008 | CN100364610C Method for raising utilizing degree to oral organism-absorbing of lumbrukinase |
| 01/30/2008 | CN100364606C Peptide compositions and formulations and use of same |
| 01/30/2008 | CN100364604C Method for producing health caring syrup using enzymolysis sugar solution as byproduct during the production of saponin from turmeric |
| 01/30/2008 | CN100364595C Compound Chinese herbal medicine of fossil, and preparation method |
| 01/30/2008 | CN100364566C Compound red sage root spray and its preparing method |
| 01/30/2008 | CN100364565C Chinese medicine composition for treating apoplexy and its preparing method |
| 01/30/2008 | CN100364563C Combination for restraining p38 subfanmily of protein kinase activated by mitogen and application |
| 01/30/2008 | CN100364557C Method for preparing confervoide oil and medicine containing thereof |
| 01/30/2008 | CN100364545C Dogwood fruit extract and its preparing method and use |
| 01/30/2008 | CN100364538C Application of fugillin in treating immunity entiritis and related immunity disease |
| 01/30/2008 | CN100364535C Medicine for preventing and treating stiff lump caused by phlebitis and injection |
| 01/30/2008 | CN100364532C Composition containing amlodipine and angiotensin II receptor inhibitor |
| 01/30/2008 | CN100364503C Dripping pills for treating coronary disease |
| 01/30/2008 | CN100364444C Cereal based food product comprising DHA and/or EPA |
| 01/29/2008 | US7323587 Selective estrogen receptor modulators |
| 01/29/2008 | US7323494 Liver X receptor(LXR) modulating agents, agonists; useful in increasing ABCA1, ABCG1, and apolipoprotein E expression, increasing cholesterol efflux from peripheral cells, treating cardiovascular disease, inflammation; 2-[2-{[4-methoxy-benzyl](2,2-diphenylethyl)amino}ethyl]-5-benzofuran acetic acid |
| 01/29/2008 | US7323493 Tablet form for oral administration of amiodarone hydrochloride or dronedarone hydrochloride; antiarrhythmic agents |
| 01/29/2008 | US7323491 Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| 01/29/2008 | US7323489 As prodrug of enalaprilat, which is a medicine useful for preventing or treating circulatory diseases such as hypertension, cardiac diseases, nephritis, and apoplexy, patches; 1-[N-[(1S)-1-Carboxy-3-phenylpropyl]-L-alanyl]-L-proline 2-hydroxyethyl ester |
| 01/29/2008 | US7323487 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 01/29/2008 | US7323486 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 01/29/2008 | US7323478 Phenylcycloalkylmethylamino and phenylalkenylamino derivatives, including 1-phenyl-2-aminomethylcyclopropanes; therapy of metabolic, feeding, and sexual disorders including obesity |
| 01/29/2008 | US7323474 Pyridine derivatives inhibiting angiogenesis and/or VEGF receptor tyrosine kinase |
| 01/29/2008 | US7323473 Administering (S)-1-(2,3,7,8-tetrahydrofuro[2,3-g]indol-1-yl)-2-propylamine; serotonin receptor antagonists (5HT/5HT2C) for treatment of obesity |
| 01/29/2008 | US7323472 Antiarthritic agents; sepsis shock; malaria; antiischemic agents; respiratory system disorders; brain disorders; congestive heart failure |
| 01/29/2008 | US7323467 3-heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-b]indole-1-acetamide derivatives, their preparation and their application in therapeutics |
| 01/29/2008 | US7323465 Alkansulfonamides as endothelin antagonists |
| 01/29/2008 | US7323461 Use of methylene blue and related compounds to prevent or reverse an exaggerated hemodynamic reaction |
| 01/29/2008 | US7323458 Dihydrobenzodiazepins and their use for treating dyslipidemia |
| 01/29/2008 | US7323457 Containing a perhydro-4-benzodiazepinylphenyl group 1-substituted with a methylaminoacetyl-, 4-piperidinylcarbonyl- or 2-pyrrolidinylcarbonyl- group: 4-(Piperidin-4-yl)carbonyl-1-{[2-(2-benzofuranoyl)amino]-4-[1-aminocarbonyl-2-(2-naphthyl)ethylamino]carbonylaminophenyl}homopiperazine; osteoporosis |
| 01/29/2008 | US7323456 Carboxylic acid derivatives compounds and agents comprising the compounds as active ingredient |
| 01/29/2008 | US7323316 Glycosyltransferase inhibitors |
| 01/29/2008 | US7323174 Modulation of immune response and methods based thereon |
| 01/29/2008 | CA2395698C Reconstructing organs from decellularized biomaterial scaffold |
| 01/29/2008 | CA2311423C Method for treating hyperlipidemia |
| 01/29/2008 | CA2226058C 8-substituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives |
| 01/24/2008 | WO2008011094A2 Cytokine induction of selectin ligands on cells |
| 01/24/2008 | WO2008010567A1 Salt or solvate of 5-methyl-2-(piperazin-1-yl)benzenesulfonic acid |
| 01/24/2008 | WO2008010566A1 Crystalline polymorphism of 5-methyl-2-(piperazin-1-yl)benzenesulfonic acid |
| 01/24/2008 | WO2008010463A1 Polymer conjugate of combretastatin |
| 01/24/2008 | WO2008010362A1 Powder of vitamin e/proline complex and method of producing the same |
| 01/24/2008 | WO2008010335A1 Plant extract having arthritis-preventive effect |
| 01/24/2008 | WO2008010225A2 Enhancement of regulatory t cells' activity using statins |
| 01/24/2008 | WO2008009954A1 Medical use of cyclin dependent kinases inhibitors |
| 01/24/2008 | WO2008009935A1 Pharmaceutical compositions and their use |
| 01/24/2008 | WO2008009639A2 New indications for direct thrombin inhibitors |
| 01/24/2008 | WO2008009638A2 New indications for direct thrombin inhibitors in the cardiovascular field |